Abstract
Abstract The effects of oral contraceptives on fasting serum-lipid and low-density-lipoprotein levels have been studied longitudinally in two groups of women. Group A consisted of 116 women tested before and during therapy, and group B comprised 48 women initially tested during therapy and again after this had been discontinued. In both groups, oral-contraceptive therapy was associated with significantly elevated mean serum triglyceride and cholesterol levels. Elevated mean fasting S f 0-12, S f 20-100, and S f 100-400 serum-lipoprotein levels were found during therapy, but S f 12-20 lipoprotein and chylomicron triglyceride levels were unchanged. The rate of flotation of the modal component of the S f 0-12 lipoproteins (S f 0-12) was reduced during therapy. Serum-triglyceride levels increased in 95% of group-A women during therapy, and decreased in 88% of group-B women after therapy was discontinued. No relation was found between the magnitude of change and nature of œstrogen-progestagen combination, day of treatment cycle, duration of therapy, degree of obesity, parity, family history of diabetes mellitus, or oral glucose tolerance.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
